全文获取类型
收费全文 | 15766篇 |
免费 | 1389篇 |
国内免费 | 1597篇 |
专业分类
18752篇 |
出版年
2024年 | 37篇 |
2023年 | 222篇 |
2022年 | 578篇 |
2021年 | 871篇 |
2020年 | 659篇 |
2019年 | 751篇 |
2018年 | 715篇 |
2017年 | 524篇 |
2016年 | 675篇 |
2015年 | 994篇 |
2014年 | 1152篇 |
2013年 | 1277篇 |
2012年 | 1528篇 |
2011年 | 1284篇 |
2010年 | 790篇 |
2009年 | 758篇 |
2008年 | 818篇 |
2007年 | 690篇 |
2006年 | 604篇 |
2005年 | 550篇 |
2004年 | 396篇 |
2003年 | 397篇 |
2002年 | 357篇 |
2001年 | 243篇 |
2000年 | 208篇 |
1999年 | 238篇 |
1998年 | 134篇 |
1997年 | 144篇 |
1996年 | 137篇 |
1995年 | 120篇 |
1994年 | 116篇 |
1993年 | 88篇 |
1992年 | 96篇 |
1991年 | 74篇 |
1990年 | 82篇 |
1989年 | 61篇 |
1988年 | 58篇 |
1987年 | 43篇 |
1986年 | 50篇 |
1985年 | 50篇 |
1984年 | 33篇 |
1983年 | 21篇 |
1982年 | 22篇 |
1981年 | 11篇 |
1980年 | 10篇 |
1979年 | 16篇 |
1978年 | 6篇 |
1977年 | 12篇 |
1976年 | 9篇 |
1973年 | 9篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
991.
Sheng Zhang Xueqiang Peng Shuo Yang Xinyu Li Mingyao Huang Shibo Wei Jiaxing Liu Guangpeng He Hongyu Zheng Liang Yang Hangyu Li Qing Fan 《Cell death & disease》2022,13(2)
Autophagy is a conserved method of quality control in which cytoplasmic contents are degraded via lysosomes. Lipophagy, a form of selective autophagy and a novel type of lipid metabolism, has recently received much attention. Lipophagy is defined as the autophagic degradation of intracellular lipid droplets (LDs). Although much remains unknown, lipophagy appears to play a significant role in many organisms, cell types, metabolic states, and diseases. It participates in the regulation of intracellular lipid storage, intracellular free lipid levels (e.g., fatty acids), and energy balance. However, it remains unclear how intracellular lipids regulate autophagy. Impaired lipophagy can cause cells to become sensitive to death stimuli and may be responsible for the onset of a variety of diseases, including nonalcoholic fatty liver disease and metabolic syndrome. Like autophagy, the role of lipophagy in cancer is poorly understood, although analysis of specific autophagy receptors has helped to expand the diversity of chemotherapeutic targets. These studies have stimulated increasing interest in the role of lipophagy in the pathogenesis and treatment of cancer and other human diseases.Subject terms: Autophagy, Mechanisms of disease 相似文献
992.
Zhiling Zhou Jiaxin Zhan Qiong Luo Xinghua Hou Shuxia Wang Dingzhang Xiao Zhi Xie Haidan Liang Shuguang Lin Meng Zheng 《Cell death & disease》2022,13(2)
Metastatic tumors are mainly composed of neoplastic cells escaping from the primary tumor and inflammatory cells egressing from bone marrow. Cancer cell and inflammatory cell are remained in the state of immaturity during migration to distant organs. Here, we show that ADRB3 is crucial in cell mobilization and differentiation. Immunohistochemistry revealed ADRB3 expression is significantly more frequent in breast cancer tissues than in adjacent noncancerous tissues (92.1% vs. 31.5%). Expression of ADRB3 correlated with malignant degree, TNM stage and poor prognosis. Moreover, ADRB3 expression was markedly high in activated disseminated tumor cells, myeloid-derived suppressor cells (MDSCs), lymphocytes and neutrophil extracellular traps of patients. Importantly, ADRB3 promoted the expansion of MDSC through stimulation of bone marrow mobilization and inhibiting of the differentiation of immature myeloid cells. Furthermore, ADRB3 promoted MCF-7 cells proliferation and inhibited transdifferentiation into adipocyte-like cell by activating mTOR pathway. Ultimately, the MDSC-deficient phenotype of ADRB3 -/- PyMT mice was associated with impairment of mammary tumorigenesis and reduction in pulmonary metastasis. Collectively, ADRB3 promotes metastasis by inducing mobilization and inhibiting differentiation of both breast cancer cells and MDSCs.Subject terms: Breast cancer, Breast cancer 相似文献
993.
994.
人类活动造成大气二氧化碳(CO2)浓度不断升高,使当今世界面临着气候变化的重大危机。微生物CO2固定为实现地球“碳中和”提供了一条有前景的绿色发展路线。与自养微生物相比,异养微生物具有更快的生长速度和更先进的遗传工具,但是其固定CO2的能力还很有限。近年来,基于合成生物学技术强化异养微生物CO2固定受到诸多关注,主要包括优化能量供给、改造羧化途径以及基于异养微生物间接固定CO2。本综述将围绕上述3个方面重点讨论异养微生物CO2固定的研究进展,为将来更好地利用微生物CO2固定技术实现“碳达峰、碳中和”提供参考。 相似文献
995.
996.
997.
Monika Jain Bagher Golzarroshan ChiaLiang Lin Sashank Agrawal WeiHsuan Tang ChiuJu Wu Hanna S. Yuan 《Protein science : a publication of the Protein Society》2022,31(5)
Human Suv3 is a unique homodimeric helicase that constitutes the major component of the mitochondrial degradosome to work cooperatively with exoribonuclease PNPase for efficient RNA decay. However, the molecular mechanism of how Suv3 is assembled into a homodimer to unwind RNA remains elusive. Here, we show that dimeric Suv3 preferentially binds to and unwinds DNA–DNA, DNA–RNA, and RNA–RNA duplexes with a long 3′ overhang (≥10 nucleotides). The C‐terminal tail (CTT)‐truncated Suv3 (Suv3ΔC) becomes a monomeric protein that binds to and unwinds duplex substrates with ~six to sevenfold lower activities relative to dimeric Suv3. Only dimeric Suv3, but not monomeric Suv3ΔC, binds RNA independently of ATP or ADP, and is capable of interacting with PNPase, indicating that dimeric Suv3 assembly ensures its continuous association with RNA and PNPase during ATP hydrolysis cycles for efficient RNA degradation. We further determined the crystal structure of the apo‐form of Suv3ΔC, and SAXS structures of dimeric Suv3 and PNPase–Suv3 complex, showing that dimeric Suv3 caps on the top of PNPase via interactions with S1 domains, and forms a dumbbell‐shaped degradosome complex with PNPase. Overall, this study reveals that Suv3 is assembled into a dimeric helicase by its CTT for efficient and persistent RNA binding and unwinding to facilitate interactions with PNPase, promote RNA degradation, and maintain mitochondrial genome integrity and homeostasis. 相似文献
998.
Cailian Fan Sui Liang Mengnan Ye Wanjun Cai Miao Chen Yunlong Hou Jun Guo Yi Dai 《Journal of cellular and molecular medicine》2022,26(9):2607
Pathological cardiac hypertrophy is the most important risk factor for developing chronic heart failure. Therefore, the discovery of novel agents for treating pathological cardiac hypertrophy remains urgent. In the present study, we examined the therapeutic effect and mechanism of periplocymarin (PM)‐mediated protection against pathological cardiac hypertrophy using angiotensinII (AngII)‐stimulated cardiac hypertrophy in H9c2 cells and transverse aortic constriction (TAC)‐induced cardiac hypertrophy in mice. In vitro, PM treatment significantly reduced the surface area of H9c2 cells and expressions of hypertrophy‐related proteins. Meanwhile, PM markedly down‐regulated AngII‐induced translocation of p‐STAT3 into the nuclei and enhanced the phosphorylation levels of JAK2 and STAT3 proteins. The STAT3 specific inhibitor S3I‐201 or siRNA‐mediated depleted expression could alleviate AngII‐induced cardiac hypertrophy in H9c2 cells following PM treatment; however, PM failed to reduce the expressions of hypertrophy‐related proteins and phosphorylated STAT3 in STAT3‐overexpressing cells, indicating that PM protected against AngII‐induced cardiac hypertrophy by modulating STAT3 signalling. In vivo, PM reversed TAC‐induced cardiac hypertrophy, as determined by down‐regulating ratios of heart weight to body weight (HW/BW), heart weight to tibial length (HW/TL) and expressions of hypertrophy‐related proteins accompanied by the inhibition of the JAK2/STAT3 pathway. These results revealed that PM could effectively protect the cardiac structure and function in experimental models of pathological cardiac hypertrophy by inhibiting the JAK2/STAT3 signalling pathway. PM is expected to be a potential lead compound of the novel agents for treating pathological cardiac hypertrophy. 相似文献
999.
Ying Zhang Jun Wei Jiani Cao Kehua Zhang Yaojin Peng Hongkui Deng Jiuhong Kang Guangjin Pan Yong Zhang Boqiang Fu Shijun Hu Jie Na Yan Liu Lei Wang Lingmin Liang Huanxin Zhu Yu Zhang ZiBing Jin Jie Hao Aijin Ma Tongbiao Zhao Junying Yu 《Cell proliferation》2022,55(4)
‘Requirements for Human‐Induced Pluripotent Stem Cells’ is the first set of guidelines on human‐induced pluripotent stem cells in China, jointly drafted and agreed upon by experts from the Chinese Society for Stem Cell Research. This standard specifies the technical requirements, test methods, and instructions for use, labeling, packaging, storage, transportation, and waste handling for human‐induced pluripotent stem cells, which apply to the production and quality control of human‐induced pluripotent stem cells. It was released by the Chinese Society for Cell Biology on 9 January 2021 and came into effect on 9 April 2021. We hope that the publication of these guidelines will promote institutional establishment, acceptance, and execution of proper protocols and accelerate the international standardization of human‐induced pluripotent stem cells for applications. 相似文献
1000.